Literature DB >> 9869787

Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy.

S G Elner1, R Strieter, Z M Bian, S Kunkel, L Mokhtarzaden, M Johnson, N Lukacs, V M Elner.   

Abstract

OBJECTIVE: To determine vitreous levels of interleukin 8 (IL-8) and interferon-induced protein 10 (IP-10), which are members of the C-X-C chemokine family that promote and inhibit neovascularization, respectively.
METHODS: We measured the levels of IL-8 and IP-10 by specific enzyme-linked immunosorbent assays in the vitreous from 30 patients with proliferative diabetic retinopathy (PDR) and 10 control patients undergoing vitrectomy for idiopathic macular holes or idiopathic macular puckers.
RESULTS: Detectable levels of IL-8 were found in 23 of 24 patients with active PDR, 4 of 6 patients with inactive PDR, and 6 of 10 controls. Levels of IL-8 were significantly increased in vitreous samples from the patients with active PDR (P = .02) when compared with vitreous samples from the controls. The IL-8 levels detected in vitreous samples from patients with inactive PDR were not significantly elevated over those found in the control samples. Interferon-induced protein 10 was detected in the vitreous samples from 23 of 24 patients with active PDR, all patients with inactive PDR, and 9 of 10 controls. Significant elevations of IP-10 were measured in samples from patients with active PDR (P = .004) and in those with inactive PDR (P = .00) over those from controls. In addition, levels of IP-10 were significantly elevated in vitreous samples from patients with inactive PDR compared with vitreous samples from patients with active PDR (P = .02).
CONCLUSION: Both IL-8 and IP-10 participate in the pathogenesis of PDR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869787     DOI: 10.1001/archopht.116.12.1597

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

Review 1.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

2.  Control of chemokine gradients by the retinal pigment epithelium.

Authors:  Guangpu Shi; Arvydas Maminishkis; Tina Banzon; Stephen Jalickee; Rong Li; Jeffrey Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

3.  Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy.

Authors:  Shuang Li; Xun-An Fu; Xiao-Fang Zhou; You-Yan Chen; Wei-Qun Chen
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

4.  Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor.

Authors:  V Stellmach; S E Crawford; W Zhou; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

5.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

Review 6.  Intraocular Inflammation in Diabetic Populations.

Authors:  Wajiha J Kheir; Huda A Sheheitli; Rola N Hamam
Journal:  Curr Diab Rep       Date:  2017-08-08       Impact factor: 4.810

7.  Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.

Authors:  Sridevi Devaraj; Ishwarlal Jialal
Journal:  Cytokine       Date:  2009-05-15       Impact factor: 3.861

8.  Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina.

Authors:  R Nicoletti; I Venza; G Ceci; M Visalli; D Teti; A Reibaldi
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

9.  Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.

Authors:  Monique S Roy; Malvin N Janal; Juan Crosby; Robert Donnelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

Review 10.  Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.

Authors:  Olga Simó-Servat; Cristina Hernández; Rafael Simó
Journal:  Mediators Inflamm       Date:  2012-09-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.